KEY FINDINGS: Implementation of a higher-dose oxytocin protocol during the third stage of labor was associated with a reduction in overall PPH, primarily driven by improved outcomes following vaginal delivery. The findings suggest that modifying oxytocin administration may represent a potentially useful approach to postpartum hemorrhage prevention. However, the study's single-center, before-and-after design limits causal interpretation. The findings do not establish the optimal oxytocin dose or demonstrate that the protocol is appropriate for all delivery settings. Further research is needed to assess safety, effectiveness across delivery modes, and reproducibility in other clinical settings.
BACKGROUND: Postpartum hemorrhage (PPH) remains a major cause of maternal morbidity and mortality. Oxytocin is routinely administered after childbirth to promote uterine contraction and prevent excessive bleeding. However, the optimal prophylactic dose and administration protocol remain uncertain. A quality-improvement study conducted at a high-volume academic medical center evaluated whether increasing the oxytocin dose administered during the third stage of labor was associated with reduced postpartum blood loss and hemorrhage.
DETAILS: The single-center quality-improvement study compared maternal outcomes before and after implementation of a high-dose oxytocin protocol at the University of Michigan Health Von Voigtlander Women's Hospital. The analysis included 2,674 births between January 1 and July 6, 2024, comprising 1,309 births before and 1,365 births after protocol implementation. The standard protocol administered 30 units of oxytocin over 1 hour, followed by 3.6 units over an additional hour. The revised protocol administered 60 units over 1 hour during the third stage of labor. Implementation involved modifications to medication orders and infusion pumps, along with staff education and training. The primary outcome was PPH, defined as quantitatively measured blood loss of 1,000 mL or greater. Secondary outcomes included quantitative blood loss, with additional analyses stratified by delivery mode. Postpartum hemorrhage occurred in 14.3% of births before implementation and 11.2% afterward (adjusted relative risk [aRR], 0.77; 95% CI, 0.64-0.93). Median quantitative blood loss decreased from 444 mL (IQR, 240-749 mL) to 396 mL (IQR, 200-673 mL), with an adjusted median difference of -43 mL (95% CI, -72 to -14 mL). Among vaginal births, PPH rates decreased from 8.5% to 5.2% (aRR, 0.60; 95% CI, 0.42-0.86). Median blood loss declined from 317 mL (IQR, 153-545 mL) to 266 mL (IQR, 147-480 mL), with an adjusted median difference of -33 mL (95% CI, -65 to -1 mL). Among cesarean births, PPH occurred in 23.4% before implementation and 21.8% afterward (aRR, 0.89; 95% CI, 0.71-1.11), indicating no statistically significant reduction.
Specialty: